NCT00464087 - Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Acute Coronary Syndromes

Interventions

DRUG

Switching from Fondaparinux to Bivalirudin or Unfractionated Heparin

Trial Locations (7)

Stony Brook University Medical Center, Stony Brook

Washington Hospital Center, Washington D.C.

University of North Carolina-Chapel Hill, Chapel Hill

Baptist Cardiac and Vascular Institute, Miami

Bridgeport Hospital, Bridgeport

Hamilton General Hospital, Hamilton

Institut Universitaire de cardiologie et de Pneumologie de Québec (Hôpital Laval), Québec